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Abstract
Background: Low back pain (LBP) is a major health issue associated with considerable health loss and societal
costs. General practitioners (GPs) play an important role in the management of LBP; however, GP care has not been
shown to be the most cost-effective approach unless exercise and behavioural counselling are added to usual care.
The Fear Reduction Exercised Early (FREE) approach to LBP has been developed to assist GPs to manage LBP by
empowering exploration and management of psychosocial barriers to recovery and provision of evidence-based
care and information. The aim of the Low Back Pain in General Practice (LBPinGP) trial is to explore whether
patients with LBP who receive care from GPs trained in the FREE approach have better outcomes than those who
receive usual care.
Methods/design: This is a cluster randomised controlled superiority trial comparing the FREE approach with usual
care for LBP management with investigator-blinded assessment of outcomes. GPs will be recruited and then cluster
randomised (in practice groups) to the intervention or control arm. Intervention arm GPs will receive training in the
FREE approach, and control arm GPs will continue to practice as usual. Patients presenting to their GP with a
primary complaint of LBP will be allocated on the basis of allocation of the GP they consult. We aim to recruit 60
GPs and 275 patients (assuming patients are recruited from 75% of GPs and an average of 5 patients per GP
complete the study, accounting for 20% patient participant dropout). Patient participants and the trial statistician
will be blind to group allocation throughout the study. Analyses will be undertaken on an intention-to-treat basis.
The primary outcome will be back-related functional impairment 6 months post-initial LBP consultation (interim
data at 2 weeks, 6 weeks and 3 months), measured with the Roland-Morris Disability Questionnaire. Secondary
patient outcomes include pain, satisfaction, quality of life, days off from work and costs of care. Secondary GP
outcomes include beliefs about pain and impairment, GP confidence, and actual and reported clinical behaviour.
Health economic and process evaluations will be conducted.
Discussion: In the LBPinGP trial, we will investigate providing an intervention during the first interaction a person
with back pain has with their GP. Because the FREE approach is used within a normal GP consultation, if effective, it
may be a cost-effective means of improving LBP care.
Trial registration: Australian New Zealand Clinical Trials Registry, ACTRN12616000888460. Registered on 6 July 2016.
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Background
Low back pain (LBP) is a highly prevalent and expensive
health condition [1–4]. At any given point in time, 18%
of the world’s population may be experiencing LBP, and
38% of people will experience LBP over the course of
1 year [5]. Back pain is one of the leading causes of
health loss globally and in New Zealand [6, 7].
Back pain has been estimated to cost 2% of gross
domestic product in developed countries [3, 4]. Health
care use represents about 15% of the total societal cost
of LBP, with the majority of costs due to absence from
work and decreased productivity [2]. Consequently,
interventions that promote early return to work and that
minimise lost productivity are likely to have the greatest
impact on the societal burden of LBP [2].
Back pain is a very common reason to visit general prac-
titioners (GPs), both internationally and in New Zealand
[1, 8, 9]. People are more likely to seek care when they
have high levels of disability and/or pain [10, 11].
Although GP care is cheaper than other treatments for
LBP, authors of a systematic review found that it is gener-
ally less cost-effective when costs associated with loss of
earnings and changes in productivity are taken into
account [12]. However, when exercise and behavioural
counselling were added to usual GP care, it became the
most cost-effective approach [12].
Factors that predict persistent LBP-related activity or
work limitation include high initial levels of pain and
impairment, psychiatric co-morbidities, low health status
and a range of psychosocial factors [13, 14]. Low pain self-
efficacy beliefs, poor expectation of recovery, elevated fear
avoidance beliefs, catastrophisation, psychological distress
(anxiety, depression and stress) and reliance on passive
coping strategies have all been found to be independently
associated with poor disability outcomes [15–23]. Those
who have more maladaptive beliefs, particularly higher
levels of fear or more catastrophic beliefs, are also more
likely to seek care [10, 24, 25].
The Fear Reduction Exercised Early (FREE) approach
was developed in New Zealand to assist GPs manage
LBP [26]. This complex intervention includes GP train-
ing, electronic consultation support and patient informa-
tion resources. Its aim is to empower GPs to explore
and address psychosocial barriers to recovery and pro-
vide evidence-based care and information to their
patients with LBP. FREE may be delivered by a GP at
the first consultation a person has for an episode of
acute LBP or during subsequent LBP consultations.
Researchers found in pilot testing that the FREE
approach was acceptable to GPs and considered to be
useful [26]. The aim of this study is to explore whether
patients with LBP who receive care from GPs who are
trained in the FREE approach have better outcomes than
those who receive usual care.
Methods/design
Aim
The primary objective of the Low Back Pain in General
Practice (LBPinGP) Study is to measure the effectiveness
of the FREE approach versus usual care for LBP in terms
of reduction in back-related functional impairment.
Secondary objectives are to (1) measure the effectiveness
of the FREE approach versus usual care for LBP in terms
of reduction in pain and increase in health-related qual-
ity of life and patient satisfaction; (2) measure the cost-
effectiveness of the FREE approach and usual care over a
period of 6 months from societal, health system and
Accident Compensation Corporation (ACC; a New
Zealand government controlled universal accident insur-
ance scheme) perspectives; and (3) consider which ele-
ments of the intervention mediate any observed changes
in health outcomes. In sensitivity analysis, we will
explore these same outcomes for new episodes of acute
LBP (defined as less than 6 weeks’ duration with no
LBP-related care received during the preceding
3 months) to explore the study’s initial hypothesis that
FREE will be most effective when received at the first
consultation for an episode of acute LBP.
Design
This study is a cluster randomised controlled superiority
trial comparing the FREE approach to usual care for
LBP management with investigator-blinded assessment
of outcomes. The Standard Protocol Items: Recommen-
dations for Interventional Trials (SPIRIT) checklist is
available as an Additional file 1.
Setting of the study
This study will be based in one geographical region
of New Zealand that has a population base of 144,550
people. Compared with the New Zealand general
population, the study population has a slightly higher
proportion of Māori and Pacific people as well as
similar proportions of people in each level of socio-
economic deprivation [27]. Patients will be recruited
from general practice clinics in this region, which has
a total of 21 practices.
Participants
General practices
Up to ten general practices will be recruited from the
study region. Practices in the region which have more
than three full-time equivalent (FTE) GPs will be invited
to participate in the trial in collaboration with their pri-
mary healthcare organisations (PHOs). Practices will not
be invited if the PHO considers that trial participation
will place an unacceptable burden due to other factors.
Recruitment will not be feasible in practices smaller than
three FTE GPs, given the low relative incidence of LBP
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presentations. Practices will enter the trial in pairs
because sequential participation of practices will permit
close contact with practices to optimise patient recruit-
ment. The sequence of participation will be planned in
collaboration with practices to enable simultaneous
recruitment from pairs of intervention and control
practices that are of similar size.
General practitioners
GPs will be invited to participate if they are registered
medical practitioners working at a general practice in
the study region that has consented to participate in the
trial. GPs will be excluded if they have participated in
pilot testing of the FREE approach. GP flow through the
trial is presented in Fig. 1. GPs invited to participate will
receive a participant information sheet. Written
informed consent will be obtained by members of the
research team.
Patients
Screening All patients presenting to participating GPs
with a primary complaint of LBP will be screened for
participation by a research nurse following a brief
explanation of the study. Patients meeting all inclusion
criteria and no exclusion criteria will be eligible for
enrolment. Patients will be enrolled and complete base-
line surveys before they see their GP. Patient flow
through the trial is presented in Fig. 2.
Inclusion/exclusion criteria This study will include
patients aged 18 years and over who present to a partici-
pating GP with LBP of any duration as their primary
complaint. Patients will not be eligible if they have had
back surgery in the last 6 months, have been unable to
do their normal work (or normal daily activities for
those who are retired, unemployed or work at home) for
more than 3 of the last 6 months, have LBP due to a
Fig. 1 General practitioner (GP) trial process. FTE Full-time equivalent
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non-back-related condition (e.g., cauda equina compres-
sion, inflammatory arthritis, malignancy, infection, aortic
stenosis or aneurysm), have a concomitant health condition
which means they are not suitable for trial participation
(e.g., pregnancy or major psychological disturbance), or are
unable to read and write in English.
Informed consent This trial complies with the
Declaration of Helsinki and has received approval from
the New Zealand Central Region Health and Disability
Ethics Committee (16/CEN/43). Because the FREE
approach is consistent with current best practice recom-
mendations [28], patients do not need to consent to
Fig. 2 Patient participant trial processes. GP General practitioner, LBP Low back pain
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receive treatment with the approach itself. Patients will
need to consent to being a research participant, but this
process will not refer to the type of treatment they may
receive. Eligible patients will receive a participant informa-
tion sheet. Written informed consent will be obtained by a
research nurse.
Concomitant care Patient care concomitant to the
FREE intervention will not be controlled or limited. It
will be monitored through the Otago Costs and Conse-
quences Questionnaire for Low Back Pain (OCC-Q-
LBP).
Participant retention
During the trial, contact will be maintained with prac-
tices by having a research nurse on site or on call during
patient enrolment, as well as regular emails and monthly
practice visits from the research team. Patients will be
sent a voucher to acknowledge their participation in
each questionnaire round. Vouchers will be delivered
with the subsequent questionnaire (so that participants
will receive a voucher at the same time as a question-
naire) to maximise responses [29, 30]. Methods of
follow-up may include text message, email, telephone
and social media [31], with participants consenting to
follow up by one or more of these methods at enrol-
ment. A website (www.lowbackpain.co.nz) will also be
used to communicate with participants and for partici-
pants to advise researchers of changes to contact details.
A further, optional consent will be obtained to follow
participants for up to 5 years through subsequent
surveys using the same instruments employed in the
present study.
Allocation arms
Intervention group
GPs in practices allocated to the intervention group will
be trained in the FREE approach. The FREE approach to
LBP was developed on the basis of a systematic review
of the literature [32], in-depth interviews with GPs and
people who had acute and chronic LBP [33–35], and a
national survey [36]. These findings were synthesised
with current research evidence on back pain, behaviour
change and guideline implementation to create a novel
approach. A full description of the development and
basis of FREE is available elsewhere [26].
The FREE approach is a complex intervention which
combines GP and patient belief change with behaviour
change approaches. The aim of FREE is to optimise the
behaviour of both GPs and patients and shift focus to
factors and behaviours which have been shown to influ-
ence outcome while reducing the provision of unhelpful,
threat-related information to patients.
Key GP behaviour change goals are (1) increased
confidence to manage back pain and reduced GP anxiety
related to screening for pathology; (2) increased under-
standing of the impact of psychosocial factors on patient
outcomes, with tools for exploring and managing these
factors; and (3) increased confidence that movement and
activity are safe, with tools for demonstrating this
confidence to patients. Key patient behaviour change
goals are (1) reduced threat associated with LBP, (2)
decreased fear of movement and decreased perceived
need to protect the back, (3) improved expectation of
outcome from a back pain episode, and (4) increased
activity and work participation.
Additional file 2 describes the behaviour change
techniques (BCTs) employed in FREE in relation to GPs.
The BCTs employed for patients are presented in
Additional file 3. These techniques are described using
the BCT taxonomy developed by Michie et al. [37].
GPs will be trained in the FREE approach through a 4-
h facilitated workshop supported with a training manual.
GPs then use the approach during a 4-week experiential
learning period. It is anticipated that GPs will see at least
three patients with LBP during the learning period. GPs
will then attend a 1-h refresher session to discuss experi-
ences and resolve any implementation difficulties. The
same investigator (BD) will lead all GP training work-
shops and refresher sessions. Patient enrolment in the
study will commence after this refresher session. The
approach also includes an electronic medical record
(EMR) tool to facilitate use of the approach, an informa-
tion booklet for patients and GPs, and an information
website accessible by both patients and GPs.
Control group
GPs within a practice allocated to the control group will
receive no training during the intervention and follow-
up periods, during which time they will continue to pro-
vide current usual care. This has been chosen as the
comparator because it is the best care available locally
outside the study. All GPs have access to current LBP
treatment guidelines.
At the end of the trial, control group GPs will be
offered an opportunity to attend the FREE workshop.
This will provide comparable benefits for being part of a
research trial.
Randomisation, allocation concealment and blinding
Randomisation
General practices will be randomly assigned to either the
intervention or control group (i.e., all GPs in a practice
will be randomised to the same arm) with a 1:1 allocation,
using a computer-generated randomisation schedule
stratified by the number of FTE GPs within the practice
(≤8 versus > 8 FTE). The aim of the stratification
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procedure is to ensure that approximately equal numbers
of GPs are allocated to the intervention and control groups.
An independent statistician will conduct the randomisation
process. Analysis of outcomes will include this practice size
stratification variable as a fixed effect to account for the
impact of this design element on study results.
GP participants will be randomised by practice for the
following two reasons: (1) Individual patient randomisation
is not feasible, because GPs may find it difficult to provide
‘usual care’ after learning about the new approach, which
would result in contamination of results from control
patients; and (2) randomisation at the level of the
individual GP (rather than practice) may result in
contamination effects if intervention GPs discuss the FREE
approach with control arm GPs within their practice.
Allocation concealment
All general practices participating in the trial (and GP
participants currently working in these practices) will be
recruited before group allocation occurs. GPs may leave
and others may join these practices (and become eligible
for the trial) during the period between randomisation
and data collection. New GPs will be kept blinded to their
practice’s group allocation until they have decided whether
to participate in the trial (using the same information as
their peers). An independent statistician at a central
administration site will perform the randomisation. The
independent statistician will communicate practice alloca-
tion to the primary investigator so that training may be
planned in intervention practices and data collection dates
can be agreed upon with all practices.
Patient recruitment will occur post-randomisation. All
eligible patients will be invited to participate. Patients will
be unaware of the trial’s existence and goals prior to pre-
senting at the practice. Patients will also be unaware that
two different treatment approaches are being compared
within the trial, meaning that patient participants will be
masked to cluster allocation. Research nurses at interven-
tion and control group practices will use identical scripts
and information sheets when approaching potential partic-
ipants, screening participants for inclusion and explaining
the study to minimise potential recruitment bias.
Blinding
The results dataset will be stored with the study arm
identity blinded by way of a unique code for each study
participant. The key to this code will be held (independent
of the dataset for analysis) by the independent statistician,
the chair of the data monitoring committee (DMC) and
the principal investigator (PI). The PI needs to know prac-
tice group allocation to conduct the intervention group
training workshops. The PI will not be involved in data
collection, entry, modification or analysis.
Individual patients will remain blind to the presence of
two study arms throughout the course of the trial.
Consultation appearance will be similar from a patient
perspective, except that intervention arm participants may
be provided a FREE booklet and referred to the FREE
website. Control arm participants may be given other
informational materials (e.g., ACC pamphlet) or be
referred to other information sites (e.g., patient.org). Even
if a patient perceives he/she is receiving a different
approach from previous GP LBP consultations, they will
remain blind to the study hypothesis.
All patient participant data submitted on paper sur-
veys will be entered or checked by a research assistant
blind to group allocation. Data entered by participants
through electronic surveys will be checked for complete-
ness and anomalous responses.
Data cleaning and analysis will be conducted by the
trial statistician who is blind to group allocation. Once
analysis is complete, the results will be unblinded. To
eliminate the risk that the trial statistician may have
been inadvertently exposed to practice codes during the
conduct of the trial, these will be replaced with new
codes in the dataset prior to the trial statistician’s receiv-
ing the data. Only the independent statistician and the
chair of the DMC will have access to the key for these
new codes.
GPs and practices will necessarily be unblinded
following group allocation because the need for training
means GPs will know whether they are in the inter-
vention or control arm prior to patient recruitment.
GPs will be aware of their study allocation when
completing baseline measures. This is necessary in
order to minimise the time between completing base-
line measures and receiving FREE training or starting
patient recruitment. The content of the intervention
will be unknown to all GPs at the time they complete
their baseline questionnaire.
Adverse events
The risks to participants in this trial are small, and no
serious adverse events or side effects attributable to the
treatment provided are expected. Patients and GPs will
be encouraged to report all potential adverse events and
incidents of serious pathology (and method of discovery)
observed amongst trial participants to the research team
on a continuous basis during the study, including
through each follow-up survey. Adverse event reports
will be reviewed by the DMC (detailed below).
Data monitoring committee
The independent DMC includes an independent statis-
tician, an independent senior researcher and an inde-
pendent academic GP. The DMC will monitor aspects
of the trial related to ethics, safety and data integrity.
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Because intervention efficacy analysis cannot be con-
ducted until 6 months post-intervention and the total
recruitment period is anticipated to be approximately
11 months, there will not be any potential for early ter-
mination of the study based on favourable or unfavour-
able results from interim analyses. Furthermore, cluster
randomised trials are not suited to interim analysis
because study power is contingent largely on the num-
ber of clusters (GPs) recruited at any point in time [38,
39]; given that this study will be recruiting patients
from clusters (GPs) in sequence, there will not be suffi-
cient data for interim analysis. Consequently, no
interim analyses will be performed.
If serious adverse events are reported to the DMC
which are unexpected and potentially related to the
intervention, the DMC will be able to break the random-
isation code to assess if the participant was part of the
intervention or control group. The DMC will be able to
provide this information to those providing health care
to the participant and will determine whether there are
grounds for stopping the trial early.
Measures
Patient-related measures are presented in Fig. 3
(SPIRIT figure patient participants; further details in
Additional file 4). GP-related measures are presented
Fig. 3 Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) figure for patient participants. *Patient participants were
assigned to intervention/control on the basis of allocation of the practice to which they presented (practices were randomized in this cluster
randomized trial). †Assessments completed prior to general practitioner consultation and intervention or control exposure. RMDQ Roland-Morris
Disability Questionnaire, NPRS Numeric Pain Rating Scale, NDRS Numeric Disability Rating Scale, EQ-5D EuroQol five dimensions, OCC-Q-LBP Otago
Costs and Consequences Questionnaire, ACC Accident Compensation Corporation, FREE Fear Reduction Exercised Early, GP General practitioner
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in Fig. 4 (SPIRIT figure GP participants; further
details in Additional file 5). Patient data will be col-
lected through surveys (electronic or postal); GP data
will be collected through surveys (electronic or pos-
tal), research nurse audio recording of consultations
and audit of clinical notes.
Patient self-reported outcomes
The primary patient-level outcome measure will be
back-related functional impairment 6 months post-initial
LBP consultation (interim data at 2 weeks, 6 weeks and
3 months), measured with the Roland-Morris Disability
Questionnaire (RMDQ) [40]. Secondary patient out-
comes are listed in Additional file 4. The RMDQ, Nu-
meric Pain Rating Scale (NPRS), satisfaction questions
[41, 42] and EuroQol five dimensions (EQ-5D) [43] are
validated tools recommended as standardised outcome
measures for LBP research [42, 44] which gather data
for the three core outcome domains recommended for
clinical trials of non-specific LBP: physical functioning
(RMDQ), pain intensity (NPRS) and health-related qual-
ity of life (EQ-5D) [44].
Patient objective outcomes
Secondary objective outcomes are the number of days off
from work, the number of days on restricted duties and the
quantity of medication taken. These will be self-reported by
the patient and collected with the OCC-Q-LBP [45]. Cost-
of-care data independently collected by ACC as part of
standard back pain claim processing will be used to
conduct a sensitivity analysis of OCC-Q-LBP data.
Patient-reported process measures
To examine the mechanisms by which FREE might
impact patient outcomes, we will collect several
patient-reported measures of pain and psychosocial
function [46–51] (Additional file 4). These are modifi-
able factors known to be predictive of disability out-
comes for LBP, and they form the targets of the FREE
approach (see Additional file 3). These measures are
collected for use as covariates for adjusting main out-
come analysis and to inform mediation analysis [52].
Some questions have been modified for consistency
(use of first person in questions for self-report, and
Likert scales all set to a 7-point range).
Fig. 4 Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) figure for general practitioner participants. *General
practitioners were enrolled between 4 weeks and 1 day pre-randomisation. †Allocation occurred between 5 weeks and 33 weeks before training
was received. ‡Time point when intervention group practices attended initial training workshops. §Assessment completed by intervention group
participants only. FREE Fear Reduction Exercised Early, HC-PAIRS Health Care Providers’ Pain and Impairment Relationship Scale, Back-PAQ Back Pain
Attitudes Questionnaire
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GP self-reported outcomes
GP-level self-reported outcomes include beliefs about
pain and impairment [53, 54], GP confidence [55] and
reported clinical behaviour [56] (Additional file 5).
GP objective outcomes
GP-level objective outcomes will be GP consultation
content recorded from EMR consultation notes by the
research nurse immediately after consults and patient
report of GP behaviour.
GP process measures
To examine the mechanisms by which FREE might impact
GP behaviour, we will collect measures related to GP
learning [57], satisfaction with training, treatment fidelity
and proposed mechanisms of impact (Additional file 5)
[58]. Intervention group GPs will record the number of
FREE consultations they conduct during the experiential
learning period. Associations between consultation count
and GP knowledge, beliefs, behaviour, confidence and
patient outcome will be analysed to explore whether a
minimum number of training consultations is required to
become competent in the approach.
Consultation recordings will be analysed to explore
whether FREE consultations are longer than usual care
LBP consultations. One consultation recording will be
randomly selected from each GP with audio recordings
available for content and thematic analysis. All consulta-
tions selected will be analysed using the Consult Audio
Recording Checklist. The researcher conducting this
analysis will be blind to group allocation.
Data management
Study data will be collected and managed using RED-
Cap (Research Electronic Data Capture) tools hosted at
the University of Otago [59]. REDCap is a secure, web-
based application designed to support data capture for
research studies.
Statistical analysis
Statistical significance will be judged with an α of 0.05.
All results will be reported as estimates of effect size
(e.g., mean difference, risk ratio, number needed to treat
[NNT]) with 95% CI. All analyses will be conducted on
an intention-to-treat basis.
Analyses will also account for clustering of data as
appropriate. For the patient-level outcomes, this cluster-
ing will be specified at the GP level using random effects
specifying the GP. Whereas randomisation is at the
practice level, clustering effects on outcome values are
expected to be driven mostly by inter-practitioner vari-
ability. For the GP-level outcomes, clustering will be
specified at the practice level. The stratified randomisa-
tion will be handled by including the practice size
stratum identifier in analytical models (less than or equal
to eight FTE GPs, more than eight FTE GPs).
In most instances, analysis will be conducted using lin-
ear mixed models (for continuous numerical outcomes
such as the RMDQ) or generalised linear mixed models
(for categorical outcomes such as satisfaction levels).
These models allow for inclusion of data from between
baseline and the final endpoint to better estimate the
differences at the main endpoint in the presence of miss-
ing follow-up data [60]. These models will be adjusted
for important baseline covariates (age, sex, socioeco-
nomic status, current back pain duration and nature
[constant or episodic], receipt of recent or ongoing non-
GP health care for back pain, previous history of back
pain, baseline disability and baseline psychological fac-
tors [pain self-efficacy and recovery expectations]) [61].
The analysis will also be adjusted for baseline Health
Care Providers’ Pain and Impairment Relationship Scale
(HC-PAIRS) scores as measured at the level of the GP
(as a measure of baseline treatment competence). We
will analyse categorical outcomes using generalised lin-
ear mixed models (conditional treatment estimates) and
generalised estimating equations (marginal treatment es-
timates) for each outcome: The former approach is to be
considered the primary analysis for that output because
the conditional treatment effect estimates relate to ex-
pected gains for each patient [60, 62].
For the primary outcome, we will report the relative
risk (RR) of a 30% improvement in RMDQ score
along with the NNT to achieve this target [63]. As a
sensitivity analysis, the NNT and RR of a 2.5-point
absolute reduction in RMDQ score will also be
reported (in line with the absolute effect size stipu-
lated for the primary outcome).
Non-inferiority criterion
If the lower bound of the 95% CI for the RMDQ
mean difference sits above −2.5 points (the minimal
clinically important difference), then we will take this
as evidence that the intervention is no worse than
current management.
Patient cost-utility analysis
By performing a cost-utility analysis, we will estimate
the mean incremental cost per quality-adjusted life-year
(QALY) gained (with QALYs to be calculated with the
NZ EQ-5D Tariff 2, as recommended by the New
Zealand Pharmaceutical Management Agency [64, 65])
from health care system, ACC and societal perspectives.
Reference costs will be assigned for (1) all health care
items to allow direct comparison and decrease patient
recall requirements, (2) paid work (based on the mean
income for someone of the participant's age and gender)
to avoid data being skewed by participants with high
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income and to make results more generalisable to the
general population, and (3) unpaid/voluntary work
(based upon the minimum wage). The human capital ap-
proach will be used for work loss. Because each patient
will be followed for 6 months, discounting will not be
necessary.
We will report the incremental cost-effectiveness ratio
and the monetary incremental net benefit with 95% CI
around the estimates. Bootstrapped data will be
displayed on a cost-effectiveness plane, and cost-
effectiveness acceptability curves will be calculated to
determine the likelihood that FREE will be considered
cost-effective using one, two and three times gross
domestic product per capita as policy-relevant
willingness-to-pay thresholds. We will report results
from sensitivity analyses by varying inputs over a range
of feasible estimates for costs or effects of important
variables that are likely to have wide variability (e.g.,
between small towns and large cities, or chance
variability introduced by large costs in a single individual
in one group).
Patient process measures
The aim of mediation analysis will be to examine the
pathways through which the intervention influences out-
comes. We will examine how changes in patient beliefs
and attitudes (process variables in Additional file 4) from
baseline to week 2 mediate the impact of FREE on the
primary outcome (RMDQ score). These analyses are be-
ing planned using structural equation modelling or
structural mean models approaches [66].
GP outcomes
As per the patient outcomes, all analyses for GP outcomes
will be conducted on an intention-to-treat basis. Cluster-
ing of responses will be handled by including a random
effect for GP practice in analytical models. Continuous
outcomes (e.g., HC-PAIRS, confidence scores) will be ana-
lysed using linear mixed models. Reported clinical behav-
iour relating to the case vignette (categorical outcome
from five options) will be compared in two ways [56]:
1. Changes in response proportions across the entire
range of responses will be compared between arms
using a generalised linear mixed model with a
cumulative logit link function (to allow for ordinal
nature of outcome), adjusted for baseline values and
including a random effect for GP practice (to handle
clustering).
2. Changes in the proportions of consultations
following ‘guideline-consistent’ reported behaviour
(in contrast to ‘guideline-inconsistent’ behaviour)
will be compared between arms using a generalised
linear mixed model with a logit link (i.e., akin to a
logistic regression specification), with responses
categorised into two levels (‘guideline-consistent’
versus ‘guideline-inconsistent’ [56]). This analysis
will be adjusted for baseline values and include a
random effect for GP practice to handle clustering.
GP behaviour in the initial LBP patient consultation will
be compared between intervention and control group GPs
using data from patient management systems and patient
report (separate analyses for recommendations regarding
work, activity and medication, as well as for referrals to
physiotherapy/osteopathy/chiropractic, specialist, x-rays or
other scans). Summary statistics will be calculated for each
GP (e.g., proportion of patients seen by that GP who
reported being advised to take time off from work) and
compared between study arms using a linear mixed model
for the mean percentage of patients meeting each indicator.
GP process measures
Process evaluation will be undertaken using mixed
methods. Both quantitative and qualitative data from a
range of participants and from various sources will be
analysed. These include the sample of audio-recorded
consultations which will be assessed for fidelity to the
FREE approach using a checklist based on FREE, EMR
data and the patient-reported consultation content, and
GP questionnaires. In order for an audio-recorded con-
sultation to be judged as being faithful to the FREE
approach, it must include (1) exploration of patient con-
cerns (item 1 from the Audio Recording Checklist), (2)
explanation and reassurance (items 4c–4f or item 7) and
(3) work and/or activity advice (item 5). The mean dur-
ation of FREE approach consultations will be compared
with control consultations using linear mixed models
(allowing for clustering by GP; no adjustment for any
baseline values).
Adverse events
The number of minor side effects, cases of serious
pathology, and serious adverse events will be compared
between groups at the end of the study.
Sample size
For 80% power to detect a between-group difference of
2.5 RMDQ points (the minimal clinically important
difference) at 6 months, assuming SD of 6.0 [67] at a p
value < 0.05 significance level, an individually rando-
mised trial would require 91 patients per group. This
has been inflated to 110 patients per group after adjust-
ment for GP cluster effects (assuming a GP intra-cluster
correlation coefficient at a conservative 0.05 and, on
average, five patients per GP completing the trial). We
aim to recruit 275 patient participants to allow for 20%
loss to follow-up.
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This design requires 22 GPs per study arm. To
account for potential zero recruitment by some GPs, we
will recruit 30 GPs per study arm. To further account
for patient loss to follow-up (assumed ~ 20% of patients
per GP) we will ask GPs to recruit seven patients. This
gives a maximal potential sample size of 210 patients per
study arm if all GPs recruit an average of 7 patients
(total sample size = 60 GPs, 420 patients). Sample size
calculations were performed using Stata 12 software
(StataCorp, College Station, TX, USA).
Trial governance
This trial has a trial management committee, a
broader trial steering committee and an independent
DMC. Roles and responsibilities are described in
Additional file 6.
Publication and dissemination
The results of this study will be disseminated regardless
of the magnitude or direction of the effect. Results will
be presented in four publications:
1. Main outcome report including the primary
outcome together with main secondary and
economic outcomes
2. Detailed health economic evaluation
3. Detailed process evaluation
4. Quantitative mediation analysis exploring the
mechanisms by which FREE might improve patients
health
The study results will be provided to the general pub-
lic and the general medical community through publica-
tion in peer-reviewed journals and presentations at
conferences. The study results will be provided directly
to study participants through email and through the
www.lowbackpain.co.nz website. During the trial, this
web address will be directed to a site providing study in-
formation appropriate for both control and intervention
group participants; results will not be published on this
site until after the trial has been completed.
Discussion
A number of tools exist to classify patients presenting
with LBP and allocate treatment on the basis of risk of
poor outcome [68, 69]. These have been found to have
acceptable predictive ability for disability outcomes but
poor predictive ability for persistent pain [70]. Encour-
aging GPs to simply apply these screening tools and plan
subsequent referred care on the basis of risk profiles
misses the opportunity for a positive therapeutic
encounter delivered by the GP at the point on entry into
the health system. Even if a GP is to base treatment
decisions on a classification process, there is still a need
to ensure this first interaction with a health practitioner
is delivered in an optimal manner and aids rather
than impedes future care. Because FREE is delivered
by a GP within normal consultation time, it does not
add cost to an episode of care. Therefore, if FREE is
found to be effective and does not increase other
costs, it may be a cost-effective method of improving
LBP care.
In a previous study in which Dutch GPs were trained
to explore and address psychosocial factors in patients
who had subacute LBP, researchers did not find any clin-
ically relevant benefits [71]. Jellema et al. [72] concluded
that this was because GPs were only moderately success-
ful at identifying psychosocial factors and postulated that
20-minute consultations were insufficient for restructur-
ing patients’ dysfunctional beliefs. The FREE approach
differs from the intervention of Jellema et al. in three
key ways. Firstly, it aims to restructure the basic GP con-
sultation rather than providing it by way of an additional
appointment. This makes the approach appear to be
standard practice rather than an add-on, allows the earli-
est possible intervention, minimises the risk of the GP
unwittingly increasing patient threat or fear through
their usual practice [73], and ensures that a consistent
approach can be used in any subsequent encounters.
Secondly, FREE bases the exploration of psychosocial
factors around the identification and minimisation of
factors which increase patient threat in relation to their
back pain rather than including all potential psycho-
social influences which may overwhelm GPs [33].
Thirdly, it also provides the patient with a booklet and
website which support and reinforce the information
provided by the GP.
Limitations
FREE was initially planned to be delivered during the
first consultation which someone receives for an episode
of acute LBP, and this study was designed to explore the
effect of FREE in this population. The study population
was expanded to include people with LBP of any dur-
ation for two reasons. Firstly, presentation rates of
eligible patients to the first recruitment sites was
unacceptably low and indicated that recruitment targets
would not be met within time frames that were accept-
able to either participating practices or the project
budget. Secondly, feedback from participating GPs indi-
cated that these restrictive recruitment criteria excluded
most of the patients with LBP they commonly saw.
Consequently, the generalisability of study findings was
likely to be limited. The revised recruitment criteria are
similar to those used in previous LBP primary care
research [67]. A sensitivity analysis of the main out-
comes will be performed restricted to the original study
population of participants with acute LBP.
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GPs will complete baseline measures post-randomisation
(but prior to receiving training). Training requires that all
participating GPs in a practice attend a 4-h training session
together. Although it would be preferable to have all GPs
complete baseline measures prior to randomisation, this is
not possible, given the lead-in time required to schedule
and co-ordinate training sessions with the practices. GPs
will be aware of whether they will receive training, but they
will not be aware of the content of the intervention when
they complete baseline measures. It is possible that know-
ledge of group allocation could affect GPs’ responses when
completing baseline measures; however, it is considered
more important that these be completed close to when
training is received and patients are recruited. GP measures
are not the trial’s main outcome, and patients are recruited
while blind to group allocation.
Trial status
This is protocol version 2 (amended 8 December 2016).
GP participants were recruited between 6 July and 8
August 2016. Patient participant recruitment began on
23 September 2016 and concluded on 31 July 2017.
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